Prophetic Patents

Freilich, Janet

doi:10.2139/ssrn.3202493

Cited by 9 publications

(9 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although patents do not constitute scientific evidence [ 356 ], the idea has been put forth, and further research would be interesting on the topic, in order to assess the feasibility of such transcutaneous CO

measurements. Prima facie , two major challenges conceivably need to be solved for DRS-based transcutaneous measurements.…”

Section: Future Applications To Transcutaneous Monitoringmentioning

confidence: 99%

Carbon Dioxide Sensing—Biomedical Applications to Human Subjects

Dervieux¹,

Théron

Uhring

2021

Sensors

View full text Add to dashboard Cite

Carbon dioxide (CO2) monitoring in human subjects is of crucial importance in medical practice. Transcutaneous monitors based on the Stow-Severinghaus electrode make a good alternative to the painful and risky arterial “blood gases” sampling. Yet, such monitors are not only expensive, but also bulky and continuously drifting, requiring frequent recalibrations by trained medical staff. Aiming at finding alternatives, the full panel of CO2 measurement techniques is thoroughly reviewed. The physicochemical working principle of each sensing technique is given, as well as some typical merit criteria, advantages, and drawbacks. An overview of the main CO2 monitoring methods and sites routinely used in clinical practice is also provided, revealing their constraints and specificities. The reviewed CO2 sensing techniques are then evaluated in view of the latter clinical constraints and transcutaneous sensing coupled to a dye-based fluorescence CO2 sensing seems to offer the best potential for the development of a future non-invasive clinical CO2 monitor.

show abstract

measurements. Prima facie , two major challenges conceivably need to be solved for DRS-based transcutaneous measurements.…”

Section: Future Applications To Transcutaneous Monitoringmentioning

confidence: 99%

Carbon Dioxide Sensing—Biomedical Applications to Human Subjects

Dervieux¹,

Théron

Uhring

2021

Sensors

View full text Add to dashboard Cite

show abstract

“…Last, one way to mitigate the risk of preemption for firms in R&D intensive industries is the usage of patents, which are frequently applied for early on in the development process (Freilich, 2018). 28 We examine this channel by differentiating between firms that are active in more or in less patent intensive industries.…”

Section: Patentsmentioning

confidence: 99%

The impact of competition and time-to-finance on corporate cash holdings

Moritzen

Schandlbauer

2020

Journal of Corporate Finance

View full text Add to dashboard Cite

“…Prophetic examples are confusing because they mimic real experiments, particularly by including excessive detail-for example, age of the hypothetical patient ("a 46-year-old woman…")-and specific, nu-merical results ("blood pressure is reduced within 3 hours…"). Some preliminary work suggests that of 100 randomly selected patents with only prophetic examples-that is, no actual data-that were cited in a scientific article or book for a specific proposition, 99 were not cited in a way that made clear that the cited information was prophetic (7). To the contrary, these prophetic patents were cited with phrases such as "[d]ehydration reaction in gas phase has been carried out over solid acid catalysts" (7), suggesting that prophetic examples mislead scientist readers.…”

Section: Prophetic Examples May Be Confusingmentioning

confidence: 99%

“…Although prophetic examples that are close variations on actual experiments are preferable, many prophetic examples appear to be entirely hypothetical predictions. Preliminary research suggests that these examples are particularly prevalent in chemistry and biology; an estimated 17% of examples in U.S. patents in these fields are prophetic, and almost one-quarter of U.S. patents in these fields have at least one prophetic example-making prophetic examples a commonplace feature (for examples, see the box) (7).…”

mentioning

confidence: 99%